ID   NW1539
AC   CVCL_S590
SY   NW-1539; NW-MEL-1539; NW-Mel-1539
DR   BTO; BTO_0005427
DR   Wikidata; Q54931193
RX   PubMed=12747757;
RX   PubMed=15087389;
CC   HLA typing: A*03,11; B*44,51; C*w04,w05 (PubMed=12747757).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 8
//
RX   PubMed=12747757;
RA   Jager, Elke
RA   Karbach, Julia
RA   Gnjatic, Sacha
RA   Jager, Dirk
RA   Maeurer, Markus J.
RA   Atmaca, Akin
RA   Arand, Michael
RA   Skipper, Jonathan C.A.
RA   Stockert, Elisabeth
RA   Chen, Yao-Tseng
RA   Old, Lloyd John
RA   Knuth, Alexander
RT   "Identification of a naturally processed NY-ESO-1 peptide recognized
RT   by CD8+ T cells in the context of HLA-B51.";
RL   Cancer Immun. 2:12-12(2002).
//
RX   PubMed=15087389; DOI=10.1158/0008-5472.CAN-03-1054;
RA   Ludwig, Ralf Joachim
RA   Boehme, Beatrice
RA   Podda, Maurizio
RA   Henschler, Reinhard
RA   Jager, Elke
RA   Tandi, Christa
RA   Boehncke, Wolf-Henning
RA   Zollner, Thomas M.
RA   Kaufmann, Roland
RA   Gille, Jens
RT   "Endothelial P-selectin as a target of heparin action in experimental
RT   melanoma lung metastasis.";
RL   Cancer Res. 64:2743-2750(2004).
//